GZL2 is an independent study conducted under the GZPL master protocol. GZL2 study will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.
GZL2 is an independent study conducted under the GZPL master protocol. GZL2 study will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
-
Elite Clinical Studies, LLC, Phoenix, Arizona, United States, 85018
Valley Clinical Trials, Inc., Covina, California, United States, 91723
Valley Clinical Trials, Inc., Northridge, California, United States, 91325
Chase Medical Research, LLC, Waterbury, Connecticut, United States, 06708
Excel Medical Clinical Trials, Boca Raton, Florida, United States, 33434
Care Access - Brandon, Brandon, Florida, United States, 33510
Northeast Research Institute - Downtown Office, Jacksonville, Florida, United States, 32204
Peace River Cardiovascular Center, Port Charlotte, Florida, United States, 33952
Care Access - Sun City Center - Cypress Village Boulevard, Sun City Center, Florida, United States, 33573
East-West Medical Research Institute, Honolulu, Hawaii, United States, 96814
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Eli Lilly and Company,
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), STUDY_DIRECTOR, Eli Lilly and Company
2027-09